Jeffrey Campbell

Jeffrey Campbell is a declared insider of Alpharma Inc, with filings sourced from SEC (Form 4). In total, 44 filings cover trades dated from 27 February 2006 to 29 December 2008.

Market trades split into 4 purchases (€45k) and 18 sales (€1.0M). Sales outweigh purchases by €969k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 11 share grants and 9 option exercises. 2008 to date brings 4 purchases and 4 sales.

A typical purchase (the median) is worth €11k.

Most recently, on 31 December 2008, the filings show a transaction in Alpharma Inc. The latest purchase dates back some time: it was published 6,703 days ago, on 16 June 2008. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.